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Executive Summary 
 
Willingness to Pay (WTP) surveys are increasingly being used in reproductive health 
programs to predict the impact of price changes on revenues, utilization and client 
profile.  The Clinical Services Improvement (CSI) project wanted to use a WTP survey to 
measure client reaction to price increases for selected services.  CSI also was interested in 
knowing whether the actual behavior of clients matched their predicted behavior in the 
WTP survey.   The FRONTIERS program worked with CSI and the Cairo Demographic 
Center (CDC) to carry out a WTP survey in 6 CSI clinics.  Following the survey, CSI 
increased the price of DMPA injections and then tracked DMPA clients over a four-
month period to determine which clients returned for subsequent injections and which did 
not. 
 
Most clients said they would be willing to pay higher prices for CSI services, and WTP 
did not vary much by client economic status.  If CSI were to implement the lower of the 
three price increases in the survey, total clinic revenues would increase, and a small 
number of CSI clients would seek services elsewhere.  Client intention to discontinue 
family planning use because of higher prices was almost non-existent.   Among DMPA 
clients, the level of agreement between stated and actual WTP was moderate; when non-
economic reasons for discontinuation were taken into account, however, agreement 
between client stated and actual WTP was much higher, both for individual clients and in 
the aggregate.  WTP surveys have the potential to be useful tools for predicting client 
response to price increases, but predictions for methods like DMPA must be adjusted to 
account for non-economic reasons for discontinuation. 
 
    
 
 
  
Introduction 
 
Concern about long-term sustainability of reproductive health programs in developing 
countries is prompting program managers to seek ways to control costs and generate 
additional income.  Charging fees to clients is one element of an overall sustainability 
strategy.1  Economic theory, however, states that demand for a good or service usually 
declines when the price is increased; thus, there are concerns that recovering more costs 
from clients will bring programs into conflict with goals to increase utilization and 
coverage, and can undermine efforts to provide services to low-income clients.  This 
dilemma between pursuit of program sustainability on the one hand and social mission on 
the other, combined with the relative inexperience of many program managers in setting 
fees, creates a sense of uncertainty and risk surrounding pricing decisions.   
 
Decisions regarding price increases would be easier to make if program managers had the 
ability to predict likely impacts of price changes on utilization, revenues and composition 
of client population.  Over the past three decades, economists have developed the 
contingent valuation (CV) method, a survey-based technique that asks respondents how 
much they would be willing to pay for a hypothetical change in the provision of a good or 
service (Mitchell and Carson, 1989).  CV surveys have been widely used in 
environmental programs to quantify program benefits for cost-benefit analysis (CBA) and 
in some cases, to guide the process of setting fees for services (Hanemann, 1994); the 
technique has also been applied in recent years to healthcare (Diener, et al., 1998).  WTP 
surveys employing the CV technique have already been used in several countries to 
predict demand for clinical services and social marketing products (Foreit and Foreit, 
2003). 
 
Managers of the Clinical Services Improvement (CSI) project – a private non-profit 
agency providing health services throughout Egypt - wanted to know whether their 
clients would be willing to pay higher prices for family planning and other reproductive 
health services.  Previous studies found evidence of willingness to pay (WTP) in Egypt 
among clients of public-sector facilities.  A study conducted by the Cairo Demographic 
Center (1997) showed that 60 percent of clients in Ministry of Health and Population 
(MOHP) clinics were willing to pay double the price they were then paying for family 
planning injectables.  Also, the Interim Demographic and Health Survey (El-Zanaty & 
Way, 2004) showed that about three-quarters of respondents (who are mostly MOHP 
clients) were willing to pay LE 5 for injectable contraceptives (LE 6.2 equivalent to 
US$1 in 2004).  CSI managers wished to measure client WTP for several specific price 
increases, and to know whether the actual purchasing behavior of individual clients 
                                                 
1 In Egypt, cost recovery is particularly relevant to the national family planning program; demand for 
contraception is rising due to the increasing number of married women of reproductive age (MWRA), 
which is expected to reach 11 million in 2017.  Also, USAID – the principal donor of family planning 
methods in Egypt for the last two decades - is gradually phasing out support for contraceptive commodities 
so that by 2007 all contraceptive methods will be purchased by the Government of Egypt (GOE).  In order 
to ensure availability of contraceptive methods, the GOE may need to consider increasing prices of 
contraceptives.  
 
  
matched their stated WTP.2  If such predictive validity could be shown, CSI could be 
confident in using WTP surveys as a tool to make informed decisions about pricing of 
services and products.  
 
Objectives 
 
1. To measure stated WTP of clients of selected RH services provided by CSI; 
2. To use information on client WTP to predict changes in clinic revenues and 
utilization; 
3. To evaluate the predictive validity of a CV survey at the level of the individual 
client, among users of the injectable DMPA. 
 
Methods 
 
1.  Design Overview 
 
For the first objective, a WTP survey was administered to CSI clients visiting outpatient 
clinics to receive selected reproductive health services.  For the second objective, survey 
results were used to simulate changes in revenues and utilization assuming various price 
changes.  For the third objective, we used a panel design in which observed client 
behavior was used to validate client-stated intentions regarding an actual increase in the 
price of DMPA.  DMPA clients were used for the validation study because their need for 
re-supply at a three-month interval ensures that a decision to return to the clinic occurs 
within a predictable timeframe.  DMPA clients that failed to return after the price 
increase were interviewed to understand the role that the price increase played in their 
decision-making.  All fieldwork activities for the study were conducted by the Cairo 
Demographic Center (CDC). 
 
2.  Selection of Study Sites 
 
The study was conducted in six clinics of CSI, an affiliate of the Egyptian Family 
Planning Association.  CSI provides services at prices that are substantially lower than 
those charged in the commercial sector.  CSI clients are mostly lower middle class 
women who cannot afford to pay high commercial sector fees and who do not seek 
services from MOHP facilities.  CSI is currently recovering 50 percent of its costs and is 
                                                 
2 Predicted willingness to pay (WTP) is useful for decision-making only if it corresponds closely to 
subsequent client behavior.  Few studies in developing countries have examined this issue.  A 1995 study 
of WTP for connections to new water systems in India found good agreement between the predicted and 
observed proportions of households that connected to the system, but a shortcoming of this study was its 
small sample size.   Onwujekwe (2004) compared predictive validity of three different question formats to 
measure WTP for insecticide-treated bednets in Nigeria.  Although the author concludes that “the findings 
give confidence that the CV method is a valid and justifiable tool for determining peoples’ valuations of 
goods and services” (p. 534), he also cautions against generalizing these results to other products and 
regions of Nigeria.  Bratt et al (2004) conducted a validation study among injectables clients in El Salvador, 
and found low predictive validity at the level of the individual client; in the aggregate, however, predictive 
validity was high because individual prediction errors in one direction were cancelled out by prediction 
errors in the other direction.   
 
  
striving for full cost recovery by 2007, when USAID completely phases out of the 
project.   
 
Criteria for clinic selection included high volumes of DMPA clients (at least 60 clients 
per month), and at least three other high-volume RH services.3  Following is a listing of 
the study clinics and the corresponding governorates where the clinics are located. 
 
Clinic Governorate 
Al-Ayat Giza 
Benha Qualyubia 
El-Delengat Beheira 
Hosh Issa Beheira 
Zagazig Sharkeya 
Zefta Gharbeya 
 
3.  WTP Survey 
 
In total, 1892 CSI clients were interviewed over a period of six weeks (February – March 
2004) regarding their stated willingness to pay higher prices for the service they had 
come to the clinic to receive.  These services included DMPA injections, IUD insertions, 
and various consultations including gynecology, prenatal and general family planning.  
Clients made the decision to participate within the context of a standard informed consent 
process administered by study staff.4 For the predictive validity objective, 414 DMPA 
clients were enrolled in the panel study.5  Selection criteria included a stated intention to 
continue using the method for at least six months (i.e., two more injections), and 
willingness to be contacted for a follow-up interview.6  New DMPA acceptors were 
excluded because lack of experience with the method was assumed to impair their ability 
to give informed answers about their willingness to pay higher prices or about continued 
use of the method. 
 
Clients were interviewed using a WTP instrument that adhered in many respects to the 
“best practices” guidelines for contingent valuation studies.7  First, the interviewer read a 
                                                 
3 WTP predictions of non-DMPA clients were not validated, but this information was collected in order to 
allow CSI management to gauge stated WTP for other services. 
4 The process was as follows: the interviewer introduced herself to the client and gave a brief introduction 
to the study.  The client then was told that if she chose to participate, her identity and the information she 
provided would be kept confidential.  She was reminded that her participation was completely voluntary, 
that she could change her mind at any time, that her decision would not affect her treatment at the clinic, 
and that there would be no compensation for participating in the study.  Finally, the interviewer asked the 
client if she agreed to participate.  
5 One client was dropped from the analysis because she switched during the index visit from injectable to 
IUD.  
6 Client consent to be contacted for follow-up was obtained separately from consent to participate in the 
WTP survey. 
7 Best practices recommendations for WTP surveys were developed by the National Oceanic and 
Atmospheric Administration (NOAA) in 1994.  These include the following: (1) rely on personal 
interviews; (2) ask respondents about a future hypothetical occurrence rather than a historical event; (3) use 
close-ended questions that elicit the respondents’ willingness to pay a specified increment for a service that 
  
brief scenario statement that summarized the circumstances surrounding the purchasing 
decision.8  This statement was developed using results from a qualitative study carried 
out with CSI clients (Brelsford, 2004), which found that respondents wanted to know the 
reasons for the price increase, and how the additional revenue would be used by CSI.  
Questions to elicit client WTP followed a “bidding game” framework, as depicted in 
Figure 1. 
 
Figure 1: Sequence of WTP Questions 
 
 Question 1 Question 2 Question 3 Question 5Question 4
What price 
do you 
currently 
pay? 
P(0) 
Would you 
pay a 
medium 
increase? 
P(2) 
Would you
pay a
higher
increase?
P(3)
Would you
pay a
lower
increase?
P(1)
What is
the
highest
price you
would pay
P(max)
What 
would you
do if the 
price were
too high?
Y
N
?
 
 
 
Each respondent first was reminded of the current price (P(0)) for the service, and then 
was asked whether she would pay a price that was somewhat higher (which we denote as 
P(2) ).  If she responded “yes” to P(2) , then she was asked whether she would pay an 
even higher price (P(3) ).  But if the response to P(2) was “no”, she then was asked if she 
would pay a price between P(0) and P(2) which we denote as P(1).  At the end of this 
process, all clients were asked to state the maximum price they would be willing to pay 
for the service, and what action they would take if the price increased to a level that was 
more than they were willing to pay or that they can afford.  We make the assumption that 
clients who responded “yes” to either P(2) or P(3) would have also responded “yes” to 
P(1).   
 
We also wanted to investigate whether client responses to WTP questions varied 
depending on client socioeconomic status.  The survey instrument included questions on 
client and spouse educational attainment, earned income, and household characteristics 
                                                                                                                                                 
is familiar to them; (4) remind respondents that the price increment reduces other consumption; (5) include 
reminders that substitutes exist for the service in question; and, (6) question respondents about factors that 
might influence their preferences. 
8 The scenario statement used was the following: “The current price in Egyptian pounds for a DMPA 
injection is LE 3.  This price includes the contraceptive product, the syringe and application of the injection 
by a nurse.  In order to continue providing high-quality services and to ensure that we always have 
adequate stocks of family planning methods, CSI has decided to increase the price of the injection.  I would 
like to ask you some questions about your response to possible changes in the price of this service.  
Suppose that your income does not change but the price of this service goes up.  Remember that you could 
get this same service at other places like the Ministry of Health or private physicians”.  
  
including type of housing and ownership of various assets.  Following a technique 
developed by Gwatkin, et. al. (2000) we used principal components analysis to compute 
an asset index from selected housing and asset variables.  This index was used as a proxy 
for client ability-to-pay (ATP), under the assumption that an index constructed from 
several indicators better reflects ATP than does a single variable like self-reported 
income.  Gwatkin’s approach assigns an “asset score” to each client depending on the 
type and number of assets owned.  These asset scores were used to divide the sample into 
ATP quintiles, which enabled us to search for associations between stated WTP of clients 
and their socioeconomic status as measured by the asset index.   
 
3.  Price Increase 
 
For the predictive validity objective, a price increase for DMPA injections was 
implemented on 4 April, 2004, approximately one month following completion of the 
WTP survey.  The price of a DMPA injection increased by LE 1 to 1.5 Egyptian pounds 
(depending on the current price in each clinic), or approximately 25 percent.  The new 
price corresponded to the amount equal to P(1) in the baseline interview.  Prices of other 
clinic services were not changed.  Before a DMPA client left the study clinic, the 
attending nurse or counselor handed her a card that indicated the date of the next 
injection and the new price for the injection. 
 
4.  Follow-up 
 
During a four-month observation period following the price increase, study staff 
monitored DMPA client follow-up patterns using existing CSI information systems.  
Interviewers from CDC contacted non-returning clients through a home interview to find 
out reasons why the client failed to return to the clinic, whether the price increase 
influenced their decision, whether they were still using a family planning method, and the 
current and future source of family planning services. 
 
5.  Data Analysis  
 
For the first objective, we computed the proportion of clients that said they would accept 
the low, medium and high price increments by service and clinic.  For the predictive 
validity objective, we constructed 2 by 2 tables in which the rows contained stated WTP 
(yes or no), and the columns contained actual client behavior (returned or did not return).  
An overall validity index consisting of the percentage of correct predictions was 
calculated.  In addition, we computed the positive predictive validity and negative 
predictive validity of the CV method and corresponding 95 percent confidence intervals.  
For these data, the positive (negative) predictive value represents the conditional 
probability that any client would (would not) return for services given that they said that 
they would (would not) return.   We also used McNemar’s test (see Stokes et al,1995) to 
test for significant agreement between predicted and actual WTP. 
  
Results 
 
1.  Stated WTP for CSI Services 
 
Figure 1 displays the results of analysis of client-stated WTP for other RH services.  
More than 80 percent of these clients said that they would pay higher prices, and more 
than half of all clients said that they would pay the highest of the three increments tested 
(information on magnitude of increments can be found in the notes to Figure 1).  For the 
first three services listed in the figure, current prices and queried increments were similar 
across all clinics, and the proportions of clients verbally accepting these increments also 
showed little variation.  Willingness to pay for IUD insertions was lower for all 
increments, probably because of the higher current price (median= LE 15) and larger 
absolute increments (LE 4.0, 7.5 and 12.5) for IUD insertions. 
 
Figure 1:  Stated Willingness to Pay for CSI services 
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Note: The exchange rate in 2004 was approximately LE 6.2 to US$1.  For gynecology, family 
planning and prenatal consultations, the median current price was LE 5, and the medians of the 
low, medium and high increments were LE 1.5, LE 2.4 and LE 4.5, respectively.  For DMPA 
injections, the median current price was LE 3.5, and the medians of the low, medium and high 
increments were LE 1, LE 2 and LE 3, respectively.  For IUD insertions, the median current price 
was LE 15, and the medians of the low, medium and high increments were LE 4, LE 7.5 and LE 
12.5, respectively. 
 
2.  Predicted Changes in Client Use of Services Following a Price Increase 
 
A concern among program managers is that price increases will encourage clients to 
abandon the use of reproductive health services.  We found very consistent responses 
across all CSI services to the question, “If the price of this service were to increase to a 
level that you did not want to pay or could not afford, where would you go for this 
service?”  For all services, approximately one-third of clients said that they would 
continue using the service at CSI regardless of the magnitude of the price (data not 
shown).  Another third said that they would go to lower-priced MOHP outlets for 
services.  The remaining third of clients included those who said they would switch to a 
lower-priced method (in the case of FP), would go to a commercial sector outlet, or did 
not know where they would go.  Only 2 percent of DMPA clients and 1 percent of IUD 
  
clients said that the price increases would result in discontinuation of family planning 
altogether. 
 
3.  Predicted Impact of Price Changes on CSI Utilization and Revenues 
 
If client predictions about future purchasing behavior are accurate, then results of the 
WTP survey can be used to predict utilization and revenues in CSI clinics after a price 
increase.  Figure 2 presents an example of such an analysis using data for DMPA 
injections.   The bars represent the proportion of all clients willing to pay each specific 
price, and the line represents total revenue that would be earned at each price level, 
assuming that client predictions are valid.  The current price is LE 3.5, and 100 percent of 
clients are assumed to be willing to pay this price since it is the current price.  WTP 
declines as the price increases; thus, when the price reaches LE 6.5, slightly more than 
half of the clients say they are willing to pay.  
 
Figure 2: Predicted changes in Utilization and Revenues related to CSI Provision of 
DMPA Injections, by Price (n=414) 
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The revenue impact of these changes in price and utilization is indicated by the line, and 
the appropriate scale is found on the right-hand vertical axis.  At the current price of LE 
3.50 and 100 percent willingness to pay, total revenue from 100 clients would be LE 350.  
If the price were to increase to LE 4.50, total revenue would rise to LE 416, even though 
utilization would decline by 7 - 8 clients.  Increasing the price to LE 5.50 would result in 
lower total revenue than at the price of 4.50, and a total of 27 lost clients.  A further 
increase in price to LE 6.50 would result in still lower total revenue and loss of 42 clients.  
Thus, raising the price for DMPA injections above LE 4.50 would make little sense, since 
both revenue and utilization would decline.  Similar analyses for other CSI services can 
be found in Appendix 1. 
 
A natural extension of this analysis is to examine what would happen to the overall 
clinic-level cost recovery ratio if price increases in the survey had been implemented (see 
table 1).  The cost recovery ratio is computed by dividing total clinic income by total 
  
clinic expenditures.  A value greater than 1.0 indicates that clinic income covers more 
than 100 percent of clinic costs, while a value less than 1.0 indicates that clinic income 
does not fully cover costs.  During the six-month period January – June 2004, cumulative 
cost recovery ratios in the six CSI study clinics ranged from 0.79 to 1.02, with an average 
of 0.91.  If CSI had implemented the low price increase for all five services, and client 
demand changed as predicted in the CV survey, cost recovery ratios in all clinics would 
have increased (see third column).  The predicted impact on utilization would be a 
reduction of 2.6 to 8.2 consultations per day, depending on the clinic.  If the medium 
price increase had been implemented, cost recovery ratios would have increased further 
in four of the six clinics.  But declines in utilization are much steeper with the medium 
price increase, ranging from 5.2 to 16.2 fewer consultations per day depending on the 
clinic. 
 
Table 1:  Predicted Impact of Price Changes on Cost Recovery Ratio (CRR) and 
Clinic Utilization, by Clinic 
 
 
 
 
 
 
 
 
Clinic 
 
 
 
 
 
 
CRR Jan – 
June 2004 
 
 
 
CRR – if 
Low 
Increment 
had been 
Implemented
 
 
 
CRR –  if 
Medium 
Increment 
had been 
Implemented
 
 
 
Change in 
utilization 
(visits per 
day) low 
increment 
 
 
Change in 
utilization 
(visits per 
day) 
medium 
increment 
      
Delengat 0.97 1.04 1.07 -3.4 -6.1 
Hosh Issa 0.88 0.91 0.86 -8.2 -16.2 
Zefta  1.02 1.08 1.05 -3.4 -7.3 
Zakazik 0.97 1.01 1.06 -2.7 -5.2 
Banha 0.87 0.90 0.94 -6.3 -8.6 
Ayat 0.79 0.89 0.93 -2.6 -6.1 
      
Total 0.91 0.96 0.98 -26.7 -49.4 
 
Note: for the low increment, absolute changes in clinic revenues over the six-month 
period would range from LE 2,070 to LE 5,648 (US$334 – US$911).  For the medium 
increment, absolute changes in clinic revenues would range from a loss of LE 1252 to a 
gain of LE 7823 (loss of US$202 to gain of US$1262). 
 
4.   Relationship between Client Ability to Pay (ATP) and Willingness to Pay 
 
A further question is whether relatively poorer CSI clients would be disproportionately 
affected by an increase in prices.  Figure 3 presents information on the relationship 
between client ability to pay (as measured by the household asset index) and client 
willingness to pay the three prompted price increments.  The CSI client population has 
been divided into five equal groups arranged according to household asset scores; for 
  
example, the “lowest” group is the bottom 20 percent of the distribution of asset scores, 
and the “highest” group is the top 20 percent of the distribution.  If a strong relationship 
existed between ATP and stated WTP, we would expect to see the lines rising sharply 
from left to right, indicating that relatively wealthier clients were more willing to pay the 
prompted increments.  For all three increments an upward trend is visible, and is 
statistically significant at the .05 level (chi-square test for trend).  But most of the upward 
movement occurs in the highest quintile; the trend-line in the lower four quintiles is 
nearly flat, and is not statistically significant for any of the three increments.  Thus, it 
appears that stated WTP does not vary much among CSI clients, especially in the lower 
80 percent of the asset index distribution. 
 
Figure 3: Stated WTP Different Price Increments, by Wealth Index Quintiles 
(n=1892) 
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Notes: P-values for the chi-square test for trend including all five quintiles: low increment p < .043; 
medium increment p < .0006; high increment p < .0007.  P-values for the chi-square test for trend including 
lower four quintiles only: low increment p < .101; medium increment p < .181; high increment p < .253. 
 
 
5.  Predictive Validity of the WTP Survey 
 
Table 2 presents findings on predictive validity of the WTP survey for all DMPA users.  
In the aggregate, the survey predicted that 383 clients out of 414 (92.5%) would return 
for a subsequent DMPA injection, and that 31 (7.5%) would not return.  Actually, 315 
clients of the 414 (76.1%) returned, while 99 clients (23.9%) did not.  Estimated positive 
predictive validity (i.e. those who actually returned given that they had said they would 
return) was 76.8%, and estimated negative predictive validity (those who did not return 
given that they had said they would not return) was 32.3%, which indicates that the WTP 
survey was much more effective in predicting who would return than who would not 
return.  The p-value for McNemar’s test was < 0.0001, suggesting that the proportion 
  
who said they would return (92.5%) was significantly different than the proportion who 
actually returned (76.1%), accounting for the pairing of the data. 
 
Table 2:  Comparison of Client Stated Willingness-to-Pay and Actual Behavior in 
Six CSI Clinics (percent of total in parentheses) 
 
Client Returned to Clinic 
After Prices Increased 
 
Client Said She Would Return 
to Clinic After Price Increase  
Yes 
 
No 
 
 
Total 
Yes 294 
(71.0%) 
89 
(21.5%) 
383 
(92.5%) 
No 21 
(5.1%) 
10 
(2.4%) 
31 
(7.5%) 
Total 315 
(76.1%) 
99 
(23.9%) 
414 
(100%) 
 
Table 2 also shows the proportion of clients who made correct versus incorrect 
predictions.  Clients in the group making correct predictions – defined as those who said 
they would return and did return, or those who said they would not return and did not 
return – totaled 304 clients (294 + 10), or 73.4 percent of all clients.  The remainder of 
clients made incorrect predictions (26.4%); most were clients who predicted that they 
would return but did not.  These clients are the most troubling from the perspective of a 
program manager using WTP to forecast revenue and utilization.  Expected revenue from 
these clients would not materialize, and utilization would be much lower than projected. 
 
Table 3 summarizes the findings of the follow-up survey that was conducted in order to 
determine client reasons for not returning to CSI for subsequent DMPA injections.  CDC 
interviewers succeeded in locating and interviewing 97 of the 99 non-returning clients.  
Of these 97 clients, approximately half were still using a method of family planning, and 
half were not.  The most common reason for not continuing to use DMPA at CSI was the 
experience of side-effects related to the method, accounting for half of non-returns 
overall.  It is well-known that many users of injectable contraceptives experience side 
effects - including changes in menstrual bleeding patterns, weight gain and headaches – 
that result in high levels of discontinuation in the first year of use (WHO, 1983; Hall et. 
al, 1994).  CSI’s own service statistics from the same time period during the previous 
year showed a discontinuation rate for DMPA clients of approximately 25 percent, nearly 
identical to the rate of 23.9 percent observed in our study.  
 
  
Table 3: Reasons for Client Discontinuation of DMPA use at CSI  
 
 
Current Use of Family Planning 
 
 
Main Reason for Not Returning 
for Next DMPA Injection 
 
Still Using FP 
 
Not Using FP 
 
 
 
Total 
    
Method-related problems 29 20 49 
Access Problems 8 6 14 
No current need for FP  0 17 17 
Economic problems 9 2 11 
Others 3 3 6 
    
Total 49 48 97 
 
Among clients still using a FP method, economic problems - including difficulty 
affording the higher price, or more generally, a problem with lack of resources to pay for 
FP – was the second-most common reason for leaving CSI.   Six of the 9 persons in this 
category reported having gone to the MOHP for subsequent service, while three obtained 
their method from private physicians or a pharmacy (data not shown).  Meanwhile, only 
two clients in the non-use group cited economic problems as the main reason for not 
returning to CSI.  Other important reasons related to problems with access to CSI clinics 
and, in the non-use group, a lack of a current need for FP (e.g. divorce, husband’s travel, 
desire for more children).  
 
Thus, while the baseline survey encouraged clients to relate their continuation intentions 
exclusively to hypothetical changes in price, the follow-up survey showed that factors 
other than the price increase motivated nearly 90 percent of the decisions to discontinue 
use of DMPA at CSI clinics.  In other words, the true relationship between client WTP 
and subsequent purchasing behavior is distorted by non-economic reasons that were 
unforeseen by clients at the time of the baseline interview.  Table 4 presents the results of 
an analysis of the relationship between stated and observed WTP in which clients 
discontinuing for non-economic reasons are removed. 
 
Table 4:  Comparison of Client-Stated Willingness-to-Pay and Actual Behavior 
(After Removing Clients who Discontinued for Non-economic Reasons) 
 
Client Returned to Clinic 
After Prices Increased 
 
Client Said She Would Return 
to Clinic After Price Increase Yes No 
 
 
Total 
Yes 294 
(89.6%) 
11 
(3.4%) 
305 
(93.0%) 
No 21 
(6.4%) 
2 
(0.6%) 
23 
(7.0%) 
Total 315 
(96.0%) 
13 
(4.0%) 
328 
(100%) 
  
In the aggregate, predictive validity of the CV survey is much improved after removing 
clients who discontinued for non-economic reasons.  The survey predicted that 305 
clients out of 328 (93%) would return, and 315 clients (96%) did, in fact, return.  At the 
individual level, the proportion of clients making correct predictions increased from 73.4 
percent to 90.2 percent, an increase of nearly 17 percentage points.  Of the 32 incorrect 
predictions, 11 were clients who said they would come back but did not; these were more 
than offset however by the 21 clients who said they would not return, but did.  Positive 
predictive validity increased to 96.4 percent (95% CI 93.8%, 98.2%) but negative 
predictive validity declined to 8.7 percent (95% CI 1.6%, 26.8%).  The p-value for 
McNemar’s test was 0.11, indicating that the proportion who said they would return 
(93%) is not significantly different than the proportion who actually returned (96%), 
when the data are paired. 
 
Conclusions 
 
Stated WTP for all services was high in the six CSI clinics, but the proportion of clients 
WTP higher prices declined as the magnitude of the queried increments increased.  WTP 
did not exhibit much variation by client socio-economic status, particularly for clients in 
the lower 80 percent of the distribution of asset index values.  This is unexpected, since 
theory predicts that WTP should vary directly with client ability to pay.  There are several 
possible explanations for this finding: the asset index could be an invalid measure of 
ATP, the spectrum of ATP of CSI clients may be narrow, or customer loyalty to CSI may 
be extraordinarily high.  A likely explanation is that the queried increments were so low 
relative to client financial resources that there was little doubt that clients would be WTP 
for services that they value.  In any case, the findings suggest that somewhat higher fees 
would be acceptable to CSI clients across the SES continuum.9   
 
Predicted changes in revenue and utilization from the low and medium increments would 
increase cost recovery in almost all CSI clinics, but as predicted by economic theory, 
these changes also would result in fewer visits to clinics.  CSI managers must weigh the 
importance of additional revenue against the reduced number of visits when deciding 
whether and how much to increase prices.  A benefit of using the WTP technique is that 
these decisions can be made on the basis of valid and reliable evidence.  In the CSI study 
clinics, concern about the impact of price increases on overall FP utilization should be 
lessened by the evidence that almost no clients would discontinue FP use altogether.  
Rather, clients would continue to obtain FP, but from different sources. 
 
This is the second recent study to evaluate predictive validity of a WTP survey at the 
individual client level.10  Although programs are interested mainly in validity of WTP in 
the aggregate, individual-level studies provide the strongest evidence for validity, and 
discontinuers can be followed up to understand the reasons for leaving the program.  We 
                                                 
9 We also asked clients their opinion of the current CSI prices, and more than 85 percent said they thought 
CSI prices were “inexpensive” or “reasonable”. 
10 The main differences between the current study in Egypt and a previous study in El Salvador were: (1) 
our focus on users of a longer-duration injectable (DMPA), and (2) our use of a more detailed scenario 
statement. 
  
found that predictive validity was low when all reasons for client discontinuation were 
included; although nearly three-quarters of DMPA clients correctly predicted their future 
purchasing behavior, more than 20 percent said they would return for a follow-up 
injection but did not return.  At the aggregate level, the WTP survey under-predicted 
drop-outs by 17 percentage points.  But when we removed clients from the analysis who 
discontinued for reasons other than the price increase, the proportion of clients making 
correct predictions increased to over 90 percent, and the aggregate-level prediction was 
almost identical to the proportion of clients who returned.  This level of predictive 
validity should be satisfactory for program managers wishing to use WTP surveys to 
predict WTP for DMPA clients.  But utilization predictions for methods like DMPA 
(which have high discontinuation for method-related reasons) must be adjusted 
downward using data on method discontinuation from program statistics or from the 
literature. 
   
 
 
  
Appendix 1: Predicted Changes in Revenue and Utilization for Other CSI Services 
 
These figures provide information on changes in revenue and utilization that could be 
expected if CSI changed its prices and the predictive validity of the WTP survey was 
high for these services.  In each figure the bars show the percentage of clients accepting 
each price increase, and the line depicts the trend in revenues associated with different 
prices and utilization levels. 
 
1.  IUD Insertions 
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2.  Family Planning Consultations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
WTP for Family Planning Consultation - All Clinics 
(n=448)
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3.  Gynecology  
 
WTP for Gynecology Visits - All clinics (n=206)
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4.  Antenatal Care 
 
WTP for Antenatal Care - All Clinics (n=269)
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